First Human Trial of Experimental Cancer-Killing Virus Underway

The CF33-hNIS virus (referred to as Vaxinia) is an oncolytic virus, a genetically-engineered variety that habitually targets cancer cells while ignoring healthy cells. But beyond infecting and killing cancer cells, Vaxinia works overtime by delivering specially-engineered white blood cells, known as CAR T cells, to solid tumors. While CAR T cells are vital to helping the body’s immune system recognize cancer cells as a threat, solid tumors possess immunosuppressive microenvironments that act as barriers, preventing the CAR T cells from entering and doing their job. By infecting solid tumors, Vaxinia can deliver the CAR T cells to this environment and help the immune system tackle cancer the way it’s supposed to—all while proactively killing off cancer cells along the way.

“Our City of Hope team designed this CF33 oncolytic virus to do what it does so well. It enters the cancer cell, uses the cell’s own machinery to replicate itself, and engineers the cancer cells to express the well-known CAR T cell target, CD19,” City of Hope’s professor of surgical oncology Dr. Yuman Fong said in a statement.

City of Hope has been working with biotechnology company Imugene Limited to develop Vaxinia since late 2020. While the two organizations have tested Vaxinia in mice, they haven’t witnessed how the virus performs in the human body—that is, until now. The first human trial began last month and will last through the end of 2024.

A total of 100 participants will receive treatment through the Phase I trial. Though all of them will receive Vaxinia on the first and eighth days of the first portion of the trial, some will receive it via IV, while the rest will receive direct tumor injections. Additionally, some participants will undergo what’s referred to as “combined” treatment using a drug called pembrolizumab, which has historically been used to treat specific types of cancers.

The trial will help calibrate the ideal dosage for adult patients and determine whether Vaxinia is safe for human use. If the trial is successful, Vaxinia could be brought to larger participant groups—and even everyday healthcare settings—in the future.

Continue reading

MSI’s Nvidia RTX 3070 Gaming X Trio Review: 2080 Ti Performance, Pascal Pricing

Nvidia's new RTX 3070 is a fabulous GPU at a good price, and the MSI RTX 3070 Gaming X Trio shows it off well.

Huawei Sells Honor Brand Amid Tightening Trade Restrictions

(Credit: Kevin Frayer/Getty Images)Huawei has been battered by US trade restrictions in the last few years, and it’s taking a toll on the company’s long-term stability. Experts don’t expect a radical change when the new US administration comes to power next year, so Huawei is beginning to take drastic action. It has sold its Honor…

IBM, Fujifilm Set New Areal Density Record With 580TB Tape Cartridge

IBM and Fujifilm have announced a breakthrough that might one day enable tape cartridges at 580TB capacities or more.

Samsung’s 870 EVO SSDs: SATA Strikes Back

Samsung's new 870 EVO is one of the fastest SSDs around — and if you need a drive in a 4TB flavor, the price isn't too bad, either.